Thorne HealthTech Valuation
| THRNDelisted Stock | USD 6.40 0.48 8.11% |
At this time, the company appears to be overvalued. Thorne HealthTech has a current Real Value of $5.0 per share. The regular price of the company is $6.4. Our model measures the value of Thorne HealthTech from inspecting the company fundamentals such as Price To Earning of 100.20 X, net income of 14.93 M, and Cash Per Share of 0.53 X as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Thorne HealthTech's price fluctuation is very steady at this time. Calculation of the real value of Thorne HealthTech is based on 3 months time horizon. Increasing Thorne HealthTech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Thorne HealthTech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Thorne Stock. However, Thorne HealthTech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.4 | Real 5.0 | Hype 6.4 | Naive 6.9 |
The intrinsic value of Thorne HealthTech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Thorne HealthTech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Thorne HealthTech helps investors to forecast how Thorne stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Thorne HealthTech more accurately as focusing exclusively on Thorne HealthTech's fundamentals will not take into account other important factors: Thorne HealthTech Total Value Analysis
Thorne HealthTech is at this time projected to have valuation of 0 with market capitalization of 259.95 M, debt of 47.03 M, and cash on hands of 27.81 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Thorne HealthTech fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 259.95 M | 47.03 M | 27.81 M |
Thorne HealthTech Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Thorne suggests not a very effective usage of assets in December.Thorne HealthTech Profitability Analysis
The company reported the previous year's revenue of 228.73 M. Net Income was 14.93 M with profit before overhead, payroll, taxes, and interest of 0.About Thorne HealthTech Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Thorne HealthTech. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Thorne HealthTech based exclusively on its fundamental and basic technical indicators. By analyzing Thorne HealthTech's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Thorne HealthTech's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Thorne HealthTech. We calculate exposure to Thorne HealthTech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Thorne HealthTech's related companies.Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York. Thorne Healthtech operates under Packaged Foods classification in the United States and is traded on NASDAQ Exchange. It employs 496 people.
Thorne HealthTech Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 52.8 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Thorne Stock
If you are still planning to invest in Thorne HealthTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thorne HealthTech's history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |